International Gemological Institute Limited (NSE:IGIL)
India · Delayed Price · Currency is INR | Market Cap | 141.16B -6.7% |
| Revenue (ttm) | 12.29B +16.7% |
| Net Income | 5.32B +24.4% |
| EPS | 12.30 +19.7% |
| Shares Out | 432.16M |
| PE Ratio | 26.56 |
| Forward PE | 24.70 |
| Dividend | 2.50 (0.77%) |
| Ex-Dividend Date | Feb 17, 2026 |
| Volume | 213,837 |
| Average Volume | 313,091 |
| Open | 325.10 |
| Previous Close | 325.85 |
| Day's Range | 324.15 - 331.45 |
| 52-Week Range | 287.00 - 442.00 |
| Beta | n/a |
| RSI | 39.68 |
| Earnings Date | May 20, 2026 |
About NSE:IGIL
International Gemological Institute Limited engages in the certification and accreditation services for natural diamonds, laboratory grown diamonds, studded jewelry, and colored gemstones in India and internationally. The company offers diamond screening and sorting, and other value-added services. It also provides education courses and programs, and professional training services through its IGI Schools of Gemology. The company was formerly known as International Gemmological Institute (India) Limited and change its name to International Gemol... [Read more]
Financial Performance
In 2025, NSE:IGIL's revenue was 12.29 billion, an increase of 16.71% compared to the previous year's 10.53 billion. Earnings were 5.32 billion, an increase of 24.41%.
Financial StatementsNews
International Gemological Institute Transcript: Q1 25/26
Q1 CY2025 saw strong sequential and year-over-year growth in revenue, EBITDA, and margins, driven by robust performance in both natural and lab-grown diamond segments. Guidance for CY2025 is 15–20% revenue growth and improved margins, with India outpacing consolidated growth.
International Gemological Institute Transcript: Q4 24/25
Q4 and full year 2025 saw robust revenue and profit growth, with strong performance across natural and lab-grown diamond segments. Margins improved, cash reserves increased, and management expects to sustain growth in FY 2026 amid stable industry conditions.
International Gemological Institute Transcript: Q3 24/25
Q3 and nine-month results showed robust double-digit growth in revenue, EBITDA, and volumes, with strong performance across all segments and geographies, especially India. Margins remained high, and the company is on track to meet or exceed full-year guidance despite macroeconomic and tariff headwinds.
International Gemological Institute Transcript: Q2 24/25
Q2 and H1 CY25 saw strong revenue and EBITDA growth, driven by robust volume increases in both natural and lab-grown diamond certification. Margins remain healthy despite one-off AI investments, and the company maintains its 15%-20% revenue growth guidance for the year.
International Gemological Institute Transcript: Q1 24/25
Q1 CY 2025 saw double-digit revenue and EBITDA growth, with strong volume gains and margin expansion. Lab-grown jewelry and international subsidiaries drove segmental growth, while pricing stabilized after last year's correction. Guidance remains robust for 2025.
International Gemological Institute Transcript: Q4 23/24
Surpassed INR 1,000 crore in consolidated revenue with 20% growth and strong margin expansion. Lab-grown diamond certification now exceeds 30% of volume, and recent acquisitions contribute 25% of group revenue. Management remains optimistic, targeting 15%-20% growth over five years.